Milind D. Chalishazar

2.0k citations
4 papers · 128 indexed · h-index 3
Topics
Nanoparticle-Based Drug Delivery (3 papers)Cancer therapeutics and mechanisms (2 papers)Cancer Research and Treatments (2 papers)
Partner nations
United StatesChina

In The Last Decade

Milind D. Chalishazar

4 papers receiving 128 citations

Peers

Milind D. Chalishazar
Comparison fields: 5 of 42
  • Molecular Biology 98
  • Cancer Research 36
  • Oncology 36
  • Epidemiology 30
  • Pulmonary and Respiratory Medicine 13
Replace Sarah Phat with:
Sarah Phat United States
Christian Baglini United States
Dzjemma Sarkisjan Netherlands
Julien Champagne Netherlands
Jennifer J. Lee United States
Zuzana Ezrova Czechia
Douglas Wilson United States
Matěj Kočík Czechia
Min Qiao China
Xi-ying Yao China
Milind D. Chalishazar relative to Sarah Phat United States Sarah Phat's profile →
Citations per field
00.5×1.5×2.2×
Sarah Phat · 1×
Citations per year

Countries citing papers authored by Milind D. Chalishazar

Since Specialization
Citations

This map shows the geographic impact of Milind D. Chalishazar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milind D. Chalishazar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milind D. Chalishazar more than expected).

Fields of papers citing papers by Milind D. Chalishazar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milind D. Chalishazar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milind D. Chalishazar. The network helps show where Milind D. Chalishazar may publish in the future.

Co-authorship network of co-authors of Milind D. Chalishazar

This figure shows the co-authorship network connecting the top 25 collaborators of Milind D. Chalishazar. A scholar is included among the top collaborators of Milind D. Chalishazar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milind D. Chalishazar. Milind D. Chalishazar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
#WorkIndexed citations
1 123
2 1
3 2
4 2

About Milind D. Chalishazar

Milind D. Chalishazar is a scholar working on Biotechnology, Biomaterials and Biomedical Engineering, having authored 4 papers that have together received 128 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), Cancer therapeutics and mechanisms (2 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Cancer Research (36 citations), Physiology (10 citations) and Molecular Biology (98 citations). Milind D. Chalishazar has collaborated with scholars based in United States and China. Frequent co-authors include Kailong Li, Trudy G. Oliver, Zeping Hu, Fang Huang, Kenneth E. Huffman, Feng Cai, Abbie S. Ireland, Jiyeon Kim, John D. Minna and Xin Liu. Their work appears in journals such as Cell Metabolism, Cancer Research and Tumor Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026